Haqq Christopher bought ELTX
February 2, 2026 · Form 4 insider transaction
Haqq Christopher bought 50,900 shares of Elicio Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
50,900
Price
$0.00
Total value
N/A
InsiderHaqq Christopher
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 2, 2026
Filing dateFebruary 3, 2026
Shares owned after50,900
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests and becomes exercisable as to 25% of the options on February 2, 2027, the first anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.